Nanophase Technologies CORP 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
Solsence, Inc. reported a decrease in total revenue for the first quarter of 2026 compared to the prior year, driven by lower sales in consumer products and advanced materials.
Solsence, Inc. reported a net loss in Q3 2025 despite nine-month revenue growth, as the company continues its strategic pivot towards consumer products.
Solsence, Inc. reported significant revenue and net income growth for Q2 2025, driven by strong performance in consumer products and a strategic shift to skin health.
Solesence Inc. reports a significant increase in revenue for Q1 2025, primarily driven by strong performance in its consumer products segment.
Nanophase Technologies Corporation saw a significant increase in revenue for the third quarter of 2024, primarily driven by its Solsence subsidiary and personal care ingredients segment.
Nanophase Technologies saw a significant increase in revenue during the second quarter of 2024, driven primarily by the growth of its Solsence beauty science subsidiary.
Nanophase Technologies saw increased revenue in Q1 2024, primarily driven by growth in its Solsence product line, despite a decrease in medical diagnostics sales.